SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
Munch-a-Biotech Today
An SI Board Since December 1998
Posts SubjectMarks Bans
3158 136 0
Emcee:  Biomaven Type:  Unmoderated
Introduction Compact
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
2258Indeed it would be wonderful to know what MRK knows that we don't..I;m interzeta1961-10/31/2006
2257Merck & Co., Inc. to Acquire Sirna Therapeutics, Inc. Monday October 30, 4:3nigel bates-10/30/2006
2256Connetics Corporation to Merge into Stiefel Laboratories Monday October 23, 5:00nigel bates-10/23/2006
2255Wow - that long. Will any of the R&D companies survive to 2011 should TeddIRWIN JAMES FRANKEL-10/18/2006
2254If they're lucky, 2011?rkrw-10/18/2006
2253When should EXEL have revenue from one or more of those drugs so they can pay thIRWIN JAMES FRANKEL-10/18/2006
2252Exel stated goal is to be a top-5 biotech, so that would place them at celgene/grkrw-10/18/2006
2251Broadening the market cap range a bit and making no judgement (since I have littsjemmeri-10/18/2006
2250They merge. Shouldn't be so tough to agree a price - EXEL isn't the mostnigel bates-10/18/2006
2249I totally dislike the 2nd part...:-) EXEL will become a govt research agency...Ldr.praveen-10/18/2006
2248mlnm can't afford exel. Only ones that could munch exel would be pharma gianrkrw-10/18/2006
2247OK, so they buy Gentium, & <b>then </b> merge with EXEL. :-)nigel bates-10/18/2006
2246Being tested in vod from stem cell transplants and also in a phase II in multiplrkrw-10/18/2006
2245Interesting idea (:-)), but I should probably have added 'in the oncology spnigel bates-10/18/2006
2244Gentium :-) Higher priced but I won't be surprised if itmn sells out now rkrw-10/18/2006
2243Call it $530m, adding in the breakup fee and subtracting expenses. <g> Knnigel bates-10/18/2006
2242So what else can MLNM get for their $515 million?sjemmeri-10/18/2006
2241Genzyme and AnorMED Reach Agreement on Acquisition Tuesday October 17, 9:13 am Enigel bates-10/17/2006
2240lol. I especially like this part. <b>Headline from ICOS: "ICOS Shkenhott-10/17/2006
2239Lilly Sets Deal to Acquire Icos for About $2.1 Billion A WALL STREET JOURNAL ONDoc Bones-10/17/2006
2238What a drawn-out, ugly end! So, Rathmann's business plan completely fails, scaram(o)uche-10/17/2006
2237They finally found someone in the company who could make a decision ?nigel bates-10/17/2006
2236ICOS, Lilly. 32/share, cash.scaram(o)uche-10/17/2006
2235mini munch Natus Medical (BABY) to acquire privately held Olympic Medical, whicIan@SI-10/16/2006
2234The Takeover Code: thetakeoverpanel.org.uk GENERAL PRINCIPLES 1. All holders onigel bates-10/12/2006
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News